Endurant Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,982	Closed	-$1.82M	–	80
2022 Q1	$1.82M	Buy	+6,982	New	+$1.66M	0.55%	41
2021 Q3	–	Sell	-7,553	Closed	-$1.52M	–	66
2021 Q2	$1.52M	Buy	+7,553	New	+$1.58M	0.42%	51
2017 Q4	–	Sell	-21,900	Closed	-$3.33M	–	90
2017 Q3	$3.33M	Buy	+21,900	New	+$3.3M	1.02%	34
2016 Q4	–	Sell	-5,150	Closed	-$449K	–	89
2016 Q3	$449K	Sell	5,150 -1,100	-18%	-$104K	0.17%	77
2016 Q2	$538K	Sell	6,250 -2,500	-29%	-$216K	0.18%	73
2016 Q1	$696K	Sell	8,750 -9,500	-52%	-$859K	0.23%	63
2015 Q4	$2.3M	Sell	18,250 -8,450	-32%	-$1.02M	0.77%	42
2015 Q3	$2.78M	Sell	26,700 -6,200	-19%	-$797K	0.93%	39
2015 Q2	$4.06M	Buy	32,900 +18,500	+128%	+$2.33M	1.2%	30
2015 Q1	$1.7M	Buy	14,400 +3,600	+33%	+$431K	0.56%	57
2014 Q4	$1.28M	Buy	+10,800	New	+$1.22M	0.5%	55